Promyelomonocytic leukemia (PML) is a prominent oncosuppressor whose inactivation is involved in the pathogenesis of hematological and epithelial cancers. Here, we report that PML aggregated in nuclear bodies in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitro. PML aggregation occurred after the fusion of nuclei (karyogamy) within syncytia but before the apoptotic program was activated. The aggregation of PML was detectable in syncytia present in the brain or lymph nodes from patients with HIV-1 infection, as well as in a fraction of blood leukocytes, correlating with viral status. Using a range of specific inhibitors of PML (the oncogenic PML/RARa fusion product or specific small interfering RNAs), we demonstrated that, in Env-elicited syncytia, PML was required for activating phosphorylation of ataxia telangiectasia mutated (ATM), which colocalized with PML in nuclear bodies, in a molecular complex that also involved topoisomerase IIb-binding protein 1. PML knockdown thus inhibited the ATM-dependent DNA damage response that culminates in the activation of p53, p53-dependent transcription of pro-apoptotic genes and cell death. Infection of CD4-expressing cells with HIV-1 also induced syncytial apoptosis, which could be suppressed by inhibiting PML. Altogether, these data indicate that PML activation is a critical early event that participates in the apoptotic demise of HIV-1-elicited syncytia.
Human immunodeficiency virus (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS), triggers T-cell depletion through apoptosis. [1] [2] [3] One particular -and poorly understood -mechanism by which HIV triggers host cell apoptosis is to induce the fusion between infected cells (which carry the HIV envelope (Env) glycoprotein complex) and uninfected cells (which carry the Env receptor CD4 and a coreceptor such as CXCR4 or CCR5). 4, 5 As a result of cell-tocell fusion (cytogamy), the cytoplasma of distinct cells is mixed and a syncytium is formed. After a latency, the nuclei contained in the common cytoplasm also fuse among each other and hence undergo karyogamy. 6, 7 Then, a complex signal transduction cascade is activated that ultimately activates the mitochondrial pathway of apoptosis. 4, [8] [9] [10] The importance of syncytial apoptosis in AIDS pathogenesis is controversial. However, a positive correlation between CD4 þ T-cell decline and infection by syncytium-inducing HIV-1 variants or orthologs has been established in vivo, in monkeys, 11 humanized SCID mice 12 and patients with AIDS. 13 Moreover, the so-called 'multinuclear giant cells', which are syncytia, accumulate in the cerebral cortex of patients with HIV-1-associated encephalopathy (HAE). The histopathological detection of such syncytia is pathognonomic for HAE, 14 meaning that their presence in frontal brain section is the sole criterion for the diagnosis of neuro-AIDS.
Karyogamy, the first step that leads to apoptotic demise of syncytia, 4, 6 requires the cyclin-dependent kinase-1 (CDK1)-mediated dissolution of the nuclear envelope and is accompanied by the mTOR-mediated phosphorylation of p53 on serine 15 (p53S15P). 6, 15 However, the sole phosphorylation of p53 on serine 15 is not sufficient to induce syncytial apoptosis, which requires a second phosphorylation of p53 on serine 46 (p53S46P). 8 As a result of karyogamy among nonsynchronized nuclei, HIV-1-elicited syncytia activate a DNA damage response involving typical DNA damage foci that contain phosphorylated histone histone 2AX (g-H2AX) as well as the H2AX-phosphorylating kinase ataxia telangiectasia mutated (ATM). 16 The activation of ATM (which is accompanied by its phosphorylation on serine 1981 (ATMS1981P)) ultimately triggers the activating phosphorylation of p38 mitogen-associated protein kinase (MAPK), which finally phosphorylates p53 on serine 46. 16 Then, p53 transactivates pro-apoptotic proteins such as Puma, thereby triggering mitochondrial membrane permeabilization, cytochrome c (Cyt c) release and caspase activation. 9 The pathway delineated above (ATM-p38 MAPK-p53-Puma) has been deciphered in syncytia generated by the coculture of Env-transfected and CD4-expressing cells, 9 and the activating phosphorylation of ATM, p38 MAPK and p53, as well as the overexpression of PUMA, has been detected in syncytia contained in the lymph nodes or brains from HIV-1-infected donors. 8, 9, 16, 17 The mechanisms through which ATM is activated within DNA damage foci of karyogamic nuclei are elusive. One particular nuclear substructure is formed by the so-called promyelomonocytic leukemia (PML) nuclear bodies (PML-NBs). 18 PML-NBs are defined by the presence of a protein called PML, a prominent oncosuppressor that is inactivated in some leukemias 19, 20 and non-small lung cancer. 19, 21 The number and size of PML-NBs increase in response to soluble factors and cellular stress, which has led to the notion that PML-NBs are stress-responsive structures. 22 Indeed, PML-NBs are dynamic structures that favor the sequestration and release of DNA repair and checkpoint proteins, mediate their post-translational modifications and promote specific nuclear events in response to various cellular stresses including DNA damage. 18, [23] [24] [25] Here, we report that PML forms large aggregates within the karyogamic syncytia of Env-elicited syncytia in vitro and in HIV-1-infected individuals. We provide evidence that PML is placed on the apex of the phosphorylation cascade involving ATM, p38 MAPK and p53. Moreover, we show that PML is required for syncytial apoptosis.
Results
Pre-apoptotic aggregation of PML in karyogamic syncytia. HIV-1 Env induces the formation of syncytia when cells transfected with HIV-1LAI Env are cultured together with cells transfected with CD4. In this model, apoptosis occurs only in syncytia (but not in single cells (SCs)), after nuclear fusion (karyogamy) has occurred and affects approximately 50% of all syncytia after 48 h of coculture. Karyogamic (but not freshly formed (pre-karyogamic) syncytia nor SCs) exhibited the aggregation of PML protein in discrete nuclear bodies (Figure 1a) without that an increase in the abundance of PML protein would be detectable by immmunoblot (Figure 1b) . Both normal and syncytial PML aggregated in a non-nucleolar pattern Table 1 ). The constant colocalization between SUMO-1 and PML before and after syncytium formation (Supplementary Figure 1) and the absence of any shift in the electrophoretic mobility of the different PML proteins (Figure 1b) Requirement of PML for the activating phosphorylation of ATM, p38 MAPK and p53. The knockdown of PML with two distinct siRNAs that target all PML isoforms had no effect on the HIV-1 Env-triggered cytoplasmic or nuclear fusion, yet reduced the expression of the p53-inducible protein Bax (S46P)), suggesting that PML acts upstream of the ATMdependent DNA damage response that triggers syncytial apoptosis. 16 PML knockdown indeed reduced the expression of ATM but not that of H2AX, p38MAPK and p53 (Figure 3a and b). PML depletion had no effect on the karyogamyassociated phosphorylation of p53 on serine 15 (p53S15P) (Figure 3a and b), yet suppressed hallmarks of apoptosis such as mitochondrial Cyt c release, caspase-3 activation and nuclear chromatin condensation ( Figure 3b ).
Similar results were obtained when PML was inhibited by another strategy, by transfection with the oncogenic fusion construct between PML and retinoic acid receptor-a (PML/ RARa), which functions as a DN inhibitor of PML. 26, 27 Syncytia that were generated from cells transfected with PML/RARa exhibited reduced nuclear PML aggregation and reduced activation of a p53-inducible green fluorescent protein (GFP) reporter gene (Figure 3c -f). Moreover, PML/ RARa abolished the entire phosphorylation cascade affecting ATM, p38 MAPK and p53 on serine 46 (but not on serine 15) as well as the hallmarks of syncytial apoptosis (Figure 3g ). These data indicate that PML is required for the activation of ATM and the MAP kinase cascade culminating in the phosphorylation of p53 on S46 and apoptosis. In contrast, PML is not required for karyogamy and the mTOR-mediated phosphorylation of p53 on S15.
Physical and/or functional interaction between PML, TopBP1 and ATM. PML inhibition by RNA interference (Figure 3a and b) or PML-RARa (Figure 3g ) prevented ATM phosphorylation in HIV-1 Env-elicited syncytia. The contribution of PML to ATM activation was not specific for syncytia, but was also found in normal HeLa cells treated with hydroxyurea (HU), etoposide, ultraviolet C light or g-irradiation. In all instances, we found that a fraction of phosphorylated ATM (ATMS1981P) colocalized with PML and that the siRNAmediated knockdown of PML reduced the activating phosphorylation of ATM (Supplementary Figure 3A-D) . These data unraveled a hitherto unsuspected link between PML and ATM in the DNA damage response. We therefore decided to investigate this link in some detail. Extraction of soluble proteins from syncytial nuclei followed by immunofluorescence staining of matrix-linked proteins suppressed the diffuse ATMS1981P staining and revealed puncta of ATMS1981P. This extraction protocol revealed a partial colocalization of PML with g-H2AX (Supplementary Figure 4A) or with the activated kinase responsible for H2AX phosphorylation, ATMS1981P (Supplementary Figure 4B) . Immunoblot experiments revealed that Env-elicited syncytia upregulated several proteins involved in the DNA damage response, in particular topoisomerase IIb-binding protein-1 (TopBP1) and Rad50 (Figure 4a ). TopBP1 and Rad50 As PML can regulate the stability of TopBP1, 23 we investigated the contribution of TopBP1 to the apoptotic cascade triggered by HIV-1 Env. Knockdown of PML reduced the syncytial expression of TopBP1, Nijmegen breakage syndrome 1 (NBS1) (Figure 5a ) and ATM (Figure 3a) . Knockdown of TopBP1 with two distinct siRNAs (Supplementary Figure 5A ) had no effect on the abundance of PML, yet reduced the amount of NBS1 and ATM in syncytia (Figure 5b ). TopBP1 depletion shifted the diffuse phosphorylation of ATM to discrete foci, reduced the size of PML nuclear bodies in syncytia (Figure 5c ) and reduced the amount of PML that coimmunoprecipitated with ATM (Supplementary Figure 5B) , proportional to the overall reduction of ATM protein (Figure 5b and Supplementary Figure 5B ). TopBP1 depletion strongly inhibited ATM phosphorylation, MAPK activation, p53S46P and apoptosis (Figure 5d and e). NBS1 depletion (Supplementary Figure  5C ) reduced the size of PML bodies (Figure 5c ), had no effect on the recruitment of TopBP1 into discrete nuclear foci (Figure 5d ), yet suppressed ATM phosphorylation (Figure 5c and d) and all downstream events (Figure 5e ). In contrast with NBS1 depletion, ATM depletion had no effect on the size of PML that remained as large as in untreated syncytia (mostly 40.5 mm) (Figure 5c ). Depletion of PML, TopBP1, NBS1 and ATM all inhibited apoptosis at a similar level of efficacy and prevented the phosphorylation of ATM substrates such as H2AX with a similar potency (Figure 5d and e) .
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These results indicate the existence of a molecular aggregate including PML, TopBP1, NBS1 and ATM that engages in a complex regulatory circuitry. PML controls the overall expression level of the three other proteins (TopBP1, NBS1 and ATM) as well as the aggregation of TopBP1 and ATM in discrete foci. TopBP1, in turn, controls the abundance of NBS1 and ATM (and exerts a mild effect on the size of PML bodies), whereas NBS1 had no effect on the abundance of the other proteins, controls the size of PML bodies and is required for the phosphorylation of ATM.
HIV-induced PML aggregation in vivo. HIV-1-induced syncytia, the so-called 'multinuclear giant cells', are most easily detectable in histological sections of the frontal cortex, where they constitute the principal diagnostic marker of HAE. 14, 28 The nuclei of such HAE-associated syncytia exhibited PML aggregation whereas normal neurons or glial cells did not, as determined by immunohistochemistry (Figure 6a ). The frequency of brain syncytia with aggregated PML was higher than that of syncytia that stained positively after terminal deoxyuridine nucleotide end labeling staining (which detects DNA fragmentation), in accord with the idea that PML aggregation occurs before apoptosis (Figure 6a) D64V at an MOI of 10 for 48 h, and the expression of the viral protein p24, the aggregation of PML, the phosphorylation of ATM or p53, and apoptosis were quantified (c). Results are plotted as the percent inhibition of the indicated parameters determined for syncytia. (d-f) Effect of PML knockdown on the syncytial apoptosis of HIV-1-infected CEM T cells. CEM cells were infected with a retrovirus vector expressing a control siRNA or an siRNA specific for PML and the depletion of PML was controlled by immunoblotting (d). Cells were then infected with wildtype HIV-1 and nuclear apoptosis was determined 72 h later (e). Moreover, the number of infectious viruses contained in the culture supernatant was determined (g). Results are means ± S.D. of four independent experiments. Asterisks indicate significant (Po0.001) effects antiviral strategies that target host proteins rather than viral gene products would have the advantage of a reduced probability of viral escape (because host proteins rarely mutate). Here, we demonstrate that syncytium formation induced by Env (in an HIV-1-free system, Figures 1-5) or HIV-1 infection (Figures 6-8 ) triggers an apoptotic pathway that involves the action of PML (Supplementary Figure 7) . An earlier report suggested that PML is recruited to recently formed HIV pre-integration complexes and ameliorates HIV-1-mediated transduction. 30 Our present study unravels a novel completely distinct role for PML in HIV-1 infection, in a pro-apoptotic signal transduction pathway that is independent of HIV-1 integrase, but dependent on the fusogenic action of Env.
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In Env-elicited syncytia, PML aggregation is an early event that is triggered by karyogamy (Figure 1 ). At present, it is not known what exact molecular events account for this karyogamy-dependent PML aggregation, although, in analogy to other system, 22 PML might sense some kind of cellular stress elicited by the formation of syncytia. The PML bodies from normal cells and those from syncytia shared some characteristics (colocalization with SUMO-1 and DAXX but not with nucleolin and MDM2), yet differed in others, in particular in the size of the PML bodies (that increased in syncytia) (Figure 5c , Supplementary Table 1), in accord with their dynamic nature. 22, 31 In addition, PML bodies from SCs and syncytia differed in their colocalization/coimmunoprecipitation with elements of the DNA damage response including ATM, g-H2AX, TopBP1 and RAD50 ( Figures 1, 4 and 5, Supplementary Figure 4 , Supplementary Table 1) . There was clearly an increase in the interaction between these latter proteins and PML in syncytia, suggesting that the 'aggregated' PML bodies (in syncytia), as opposed to 'normal' PML bodies (in SCs), sense DNA damage triggered by the fusion of nonsynchronized nuclei. It should be noted that PML aggregation was induced by different kinds of physical or chemical DNA damage, even in SCs (Supplementary Figure 3) . Moreover, we found that a particular type of PML aggregation could be induced by mitotic catastrophe. Mitotic catastrophe can be induced in syncytia by inhibiting the checkpoint kinase-2 (Chk2). Although untreated syncytia arrest their cell cycle in G2, Chk2-inhibited syncytia enter a multipolar catastrophic mitosis, followed by accelerated apoptosis. 32 In these conditions, we found that syncytia with aberrant mitotic figures manifested a major aggregation of PML in spots that were even larger than those found in karyogamic nuclei, yet were not associated with chromatin (Supplementary Figure 8A) . As knockdown of PML inhibited signs of apoptosis (such as Cyt c release and nuclear apoptosis) and did not impede the appearance of multipolar aberrant mitoses (Supplementary Figure 8B and C) , we figure) . The phosphorylation status of ATM (c), H2AX (d) and apoptosis were quantified (e). The effect of PML depletion on HIV-1 infection was evaluated by measuring b-galactosidase activity (as described in Materials and Methods) (f). Asterisks indicate significant (Po0.001) effects conclude that PML is also involved in sensing DNA stress in the context of mitotic catastrophe. Altogether, these results suggest that PML has a general role in 'sensing' DNA damage or 'genomic stress'.
In karyogamic syncytia, PML aggregation occurs upstream of ATM phosphorylation (and not vice versa) because PML depletion impeded ATM phosphorylation, whereas depletion or inhibition of ATM had no effects on PML aggregation. Our results indicate that PML and ATM colocalize and/or coimmunoprecipitate in a molecular complex that includes other proteins involved in the DNA damage response including TopBP1 and NBS1. PML depletion reduced the abundance of TopBP1, NBS1 and ATM, whereas TopBP1 depletion only reduced NBS1 and ATM (but not PML). Depletion of either TopBP1 or NBS1 reduced the size of PML bodies, whereas ATM depletion had no such effect. Knockdown of PML, TopBP1 and NBS1 all had a similar inhibitory effect on ATM phosphorylation, the phosphorylation of ATM substrates and downstream events leading to apoptosis ( Figure 5 ). These results suggest that PML, TopBP1, NBS1 and ATM interact within a syncytium-associated nuclear complex in which ToBP1 and NBS1 act as functional links between PML and ATM. However, in view of the complex regulation of DNA damage foci, 33 it is difficult to establish a linear hierarchy among these factors.
There are multiple mechanisms through which PML can modulate the activity of p53, which is the most important pro-apoptotic transcription factor in syncytia. 9 As a possibility, PML may inactivate the principal negative regulator of p53, MDM2, by sequestering it to the nucleolus. 34 However, in HIV-1 Env-elicited syncytia, MDM2 and PML do not colocalize (Supplementary Figure 2C) , and MDM2 remains largely cytoplasmic. 6 It has also been suggested that PML would stimulate the phosphorylation of p53 on serine 46 by homeodomain-interacting protein kinase 2 (HIPK2). 35 However, the knockdown of HIPK2 did not influence p53S46 phosphorylation in this system. 8 Finally, it has been suggested that PML nuclear bodies would recruit p53 to enhance p53 transactivation. 36, 37 However, in HIV-1 Env-elicited syncytia, PML and active phosphorylated p53 did not colocalize in karyogamic syncytia ( Supplementary Figure 2A and B) . Rather, our data indicate that PML influences p53 phosphorylation indirectly, through ATM and p38 MAPK. Both ATM and p38 MAPK are required for the phosphorylation of p53 in syncytia, and PML depletion inhibits the activation of ATM and p38MAPK ( Figure 3) .
It should be noted that all the elements of the pathway delineated thus far (PML-ATM-p38MAPK-p53) have been detected in vivo, in multinuclear giant cells of the HAE brain, lymph node biopsies, as well as a sub-population of PBMC (see Figure 6 as well as Perfettini et al. 8, 9, 16 ; Castedo et al. 15 ; and Nardacci et al. 17) . This implies that the results obtained in vitro, in the Env-elicited syncytia, can be extrapolated -with the necessary caution -to the pathogenesis of AIDS. Furthermore, single-nucleotide polymorphisms in the PML gene correlate with HIV disease progression in vivo. 38 The data presented here provide the first rationale to explain how mutations that affect the expression or structure of PML might impact on AIDS pathogenesis.
Materials and Methods
Antibodies, plasmids and reagents. Monoclonal (PG-M3) and polyclonal (H-238) antibodies for the detection of PML were obtained from Santa-Cruz Biotechnology Inc. Polyclonal rabbit antibodies for the detection of MKK3, MKK3 with phosphorylated serine 189 and/or MKK6 with phosphorylated serine 207, p38, p38T180/Y182P, p53S15P, p53S46P and SUMO-1 were from Cell Signaling Technology. Monoclonal antibodies against cyclin B1 or anti-Cyt c were purchased from Becton Dickinson. The polyclonal rabbit antibody against NBS1 was obtained from Calbiochem. The monoclonal antibody against NBS1S343P was from Interchim. Monoclonal antibodies used to reveal ATM, ATMS1981P, H2AX H2AXS139P, hMRE11 and Rad50 were obtained from Upstate and anti-GFP antibody, Hoechst 33342 and TOPRO3 were purchased from Invitrogen. The plasmid for Baculovirus p35 was provided by Dr. Guy Salvesen (Burnham Institute, La Jolla, CA, USA). DN mutant plasmids for Cdk1 (DN Cdk1), IKSR, DN p53 (H175) and DN p38 MAPK were described earlier. 9 The WT X4 HIV-1 proviral clone pNL4-3 and the VSV G protein (VSV-G)-pseudotyped HIV-1-based vector system have been described earlier. 39 Immunoblots and immunoprecipitation. Total cellular proteins were extracted in 250 mM NaCl-containing lysis buffer (250 mM NaCl, 0.1% NP40, 5 mM EDTA, 10 mM Na 3 VO 4 , 10 mM NaF, 5 mM DTT, 3 mM Na 4 P 2 O 7 and protease inhibitor cocktail). Protein extracts (50 mg) were run on 3 or 12% SDS-PAGE and transferred at 41C onto a nitrocellulose membrane. After incubation for 12 h in the blocking buffer (Zymed), the membranes were incubated with indicated primary antibodies at room temperature during 1 h 30 min. Then, horse radish peroxidaseconjugated goat anti-rabbit or goat anti-mouse (Southern Biotechnology) antibodies were incubated during 1 h and revealed with the enhanced ECL detection system. For immunoprecipitation, lysates (200 mg) were immunoprecipitated with anti-ATM, anti-PML or anti-TopBP1 antibodies for 2 h and incubated overnight at 41C with G-coupled sepharose beads (Roche Applied Science, Rockford, IL, USA), washed five times with lysis buffer and subjected to SDS-PAGE.
Immunofluorescence and immunohistochemistry. Cocultures were fixed in 4% paraformaldehyde/phosphate-buffered saline (PBS) for 30 min, permeabilized in 0.1% SDS in PBS and incubated with FCS for 20 min. Then, indicated sera were used for immunodetection in PBS containing 1 mg/ml BSA and revealed with goat anti-rabbit IgG conjugated to Alexa 488 (green) or Alexa 568 (red) fluorochrome from Invitrogen. To assess karyogamy and nuclear apoptosis, cells were counterstained with Hoechst 33342 (Invitrogen). Proteins attached to damaged nuclear matrix were detected by immunofluorescence microscopy using the following procedure. Briefly, living cells were incubated for 20, 10 and 5 min with a fractionation buffer (containing 50 mM Hepes, 150 mM NaCl, 1 mM EDTA, 0.2% NP40, 10 mM NaF, 10 mM glycerophosphate, 1 mM Na 3 VO 4 and protease inhibitor cocktail) at 41C before fixation. Immunohistochemistry was performed following published protocols. 8, 9, 17 RNA interference. Published siRNAs specific for ATM, 40 NBS1 (hNBS1.1 CAGGAGGAAGATGTCAATGdTdT or hNBS1.2 GGCGUGUCAGUUGAUGAAA dTdT), MKK3 (hMEKK3 GCACGGUCGACUGUUUCUAdTdT), PML (PML1.1 from Santa-Cruz or PML1.2: hPML-1225 CUCCCAGGGACCCUAUUGAdTdT), p38MAPK (Dharmacon RNATtechnology) and TopBP1 (hTopBP1.1 CUCACCUUA UUGCAGGAGAdTdT or TopBP1.2 GAACGUGGUGGCUCUAAAUdTdT) were transfected using Oligofectamine (Invitrogen), according to the manufacturer's instructions. For stable expression of short interfering RNAs against PML into CEM cell lines, the retroviral GeneSuppressor kit (Imgenex) was used. The retroviral siRNA plasmid (IMG-1000-1) included in the kit has been modified from pCLNCX vector. It contains the neomycin-resistance gene (G418) under the control of 5 0 -LTR and a cloning site downstream of the U6 promoter for the expression of hairpin siRNA. Double-stranded oligonucleotide targeting PML gene was synthesized and introduced into the IMG-1000-1 plasmid (linearized pSuppressor retro; Imgenex). This plasmid was referred to as pSupPML. We used the IMG-1000-6 plasmid Imgemex (that codes for a scrambled siRNA) as a negative control (pSup). The plasmids pSupPML and pSup were independently cotransfected with the plasmid pCL-Ampho (Amphotropic RetroMax packaging vector; Imgenex) into 293T cells using the calcium phosphate procedure. Titers of produced retroviral vectors (SupPML and pSup) were determined after infection of HeLa cells and G418 selection. CEM4fx cells were infected at a multiplicity of infection of 1. Twenty-four hours later, infected cells were selected with G418 (1 mg/ml) and amplified as a polyclonal population of cells stably transduced with pSup (CEM-control) or pSupPML (CEM-PML -).
Viral and pseudoviral constructs. Viral stocks of WT X4 HIV-1, VSV-Gpseudotyped HIV-1 and X4 HIV-1 containing integrase mutation Q62A were obtained after transfection of 293T with virus-encoding plasmids as described earlier.
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Patients. Axillary lymph node biopsies were obtained from healthy and HIV-1-infected individuals (all men, mean age 36 years, with a plasma viral load 4105 copies/ml). Plasma HIV-1 RNA levels were determined by the bDNA procedure (Versant HIV RNA 3.0; Bayer, USA). Post-mortem frontal cortex sections were obtained from seven brains of patients with HIV-1-associated dementia (but lacking secondary infections) and four control brains obtained from uninfected control patient. Human samples were obtained with written informed consent in accord with the National and European legal requirements, after approval by the Institutional Review Board of the National Institute for Infectious Disease and the Medical Faculty of the University of Rome.
